Trial
NCT02483624
3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwell Health
Collaborators
—
Condition
SLE
Intervention
BR-DIM
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-01